Other Liabilities - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Other Liabilities Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Other Liabilities
ÂŁ10.1B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
8%
A
AstraZeneca PLC
NASDAQ:AZN
Other Liabilities
$4.7B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-7%
Indivior PLC
LSE:INDV
Other Liabilities
$376m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
25%
Hikma Pharmaceuticals PLC
LSE:HIK
Other Liabilities
$80m
CAGR 3-Years
-18%
CAGR 5-Years
-24%
CAGR 10-Years
55%
Allergy Therapeutics PLC
LSE:AGY
Other Liabilities
ÂŁ8.8m
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Dechra Pharmaceuticals PLC
LSE:DPH
Other Liabilities
ÂŁ73.3m
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
28%

See Also

What is GlaxoSmithKline PLC's Other Liabilities?
Other Liabilities
10.1B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Other Liabilities amounts to 10.1B GBP.

What is GlaxoSmithKline PLC's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
8%

Over the last year, the Other Liabilities growth was 10%.

Back to Top